Stocktoria
Outset Medical, Inc. OM
Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2020-09-15
Outset Medical, Inc. financials (annual)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $119.5M | $113.7M | $130.4M | $115.4M | $102.6M | $49.9M | $15.1M |
| Gross profit | $46.8M | $38.6M | $29.0M | $17.8M | $7.6M | -$13.0M | -$17.8M |
| R&D expense | $21.2M | $38.4M | $57.3M | $48.9M | $36.7M | $28.9M | $23.3M |
| Operating income | -$66.7M | -$113.4M | -$169.8M | -$161.0M | -$130.5M | -$117.5M | -$70.3M |
| Interest expense | $14.0M | $23.9M | $12.7M | $3.6M | $1.7M | $2.9M | $4.3M |
| Income tax | $718,000 | $491,000 | $523,000 | $295,000 | $199,000 | $0 | $20,000 |
| Net income | -$81.7M | -$128.0M | -$172.8M | -$163.0M | -$131.9M | -$121.5M | -$68.3M |
| EPS (diluted) | $-5.37 | $-36.96 | $-52.28 | $-3.38 | $-2.89 | $-4.85 | — |
| Operating cash flow | -$46.3M | -$116.3M | -$131.4M | -$145.7M | -$130.3M | -$99.0M | -$70.3M |
| Free cash flow | -$47.1M | -$117.2M | -$134.8M | -$154.1M | -$133.4M | -$108.1M | -$73.6M |
| Cash & equivalents | $35.0M | $124.0M | $68.5M | $73.2M | $182.3M | $295.0M | $36.9M |
| Inventory | $47.6M | $59.4M | $49.2M | $51.5M | $39.2M | $18.4M | $4.6M |
| Total assets | $264.5M | $275.8M | $313.8M | $400.1M | $463.5M | $403.8M | $88.4M |
| Total liabilities | $137.5M | $249.0M | $190.9M | $154.1M | $89.4M | $75.2M | $51.1M |
| Shareholders' equity | $127.0M | $26.8M | $122.9M | $246.0M | $374.1M | $328.6M | -$372.2M |
Growth · year-over-year · Revenue CAGR 41.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue growth | +5.1% | -12.8% | +13.0% | +12.4% | +105.5% | +231.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.